FTC Seeks More Info On Watson, Arrow Merger
The Federal Trade Commission has issued a second request to Watson Pharmaceuticals Inc. for more information regarding its proposed merger with generics maker Arrow Group....To view the full article, register now.
Already a subscriber? Click here to view full article